This compound is a salt form of a bicyclic amino acid derivative used as a pharmaceutical intermediate.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1373205-30-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid
Pharmaceutical intermediate
(Z)-[AMINO(4-AMINOPHENYL)METHYLIDENE]AMINO 4-CHLOROBENZOATE
Pharmaceutical intermediate for impurity synthesis
Dapagliflozin Impurity D
reference standard for impurity testing
Boc-lysine
protected amino acid for peptide synthesis
N-(tert-Butoxycarbonyl)-L-phenylalanine
Boc-protected amino acid intermediate
METHYL (1R,2S,5S)-6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXYLATE HYDROCHLORIDE
Pharmaceutical intermediate
(1R,2S,5S)-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxylic acid
Pharmaceutical intermediate for nirmatrelvir synthesis
(1R,2S,5S)-methyl 3-((S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate
Boc-protected amino acid building block
(1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid;hydrochloride
RWFNAAZDBOSSIY-YCLXABBFSA-N
CC1([C@@H]2[C@H]1[C@H](NC2)C(=O)O)C.Cl
—